Mirati Therapeutics
MRTX
$58.70
Share price
0.00%
Change (1 day)
29.75%
Change (1 year)
Categories
P/S ratio for Mirati Therapeutics (MRTX)
P/S ratio as of May 2024 (TTM): 108
According to Mirati Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 107.818. At the end of 2023 the company had a P/S ratio of 79.7.
P/S ratio history for Mirati Therapeutics from 2009 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 79.7 | -62.01% |
| 2022 | 210 | 86.58% |
| 2021 | 112 | -86.36% |
| 2020 | 824 | -46.02% |
| 2019 | > 1000 | 1329.88% |
| 2018 | 107 | |
| 2017 | N/A | |
| 2016 | N/A | |
| 2015 | N/A | |
| 2014 | N/A | |
| 2013 | N/A | -100% |
| 2012 | 46.7 | 119.55% |
| 2011 | 21.3 | 795.66% |
| 2010 | 2.37 | -43.92% |
| 2009 | 4.23 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 TravelCenters of America TA | 0.1204 | -99.89% | 🇺🇸 USA |
 Nymox Pharmaceutical NYMX | N/A | N/A | Bahamas |